Skip to main content
NVO logo

Novo Nordisk A/S

NVONYSEHealthcareDrug Manufacturers - General

$39.13Today:- (-)1Y −25.93%

As of Oct 26, 2026 close

Market cap
$173.57B
P/E (TTM)
9.98
Forward P/E
9.57
Dividend yield
4.56%
52-week range
$35.12$64.16
Volume (live)
-
Avg. volume (3M)
12.83M

Novo Nordisk A/S (NVO) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Novo Nordisk A/S stock.

Analyst Consensus Rating

Investment consensus from 14 professional research analysts

Consensus Rating

Hold
Based on 14 unique analysts
(22 total ratings in last 90 days)
High Confidence0

Average Price Target

$42.53
+8.69% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest NVO Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Sundeep Ganoria
Zacks Equity Research
HoldInitiates Coverage
-
Kerry Holford
Berenberg Bank
HoldMaintains
$47.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Evan Seigerman
BMO Capital
HoldMaintains
$47.00 → $40.00
Ahan Chakraborty
Zacks Equity Research
HoldInitiates Coverage
-
Evan Seigerman
BMO Capital
HoldMaintains
$47.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Evan Seigerman
BMO Capital
HoldMaintains
$47.00
Ahan Chakraborty
Zacks Equity Research
HoldInitiates Coverage
-
Michael Nedelcovych
TD Cowen
HoldMaintains
$42.00
Unknown Analyst
Jefferies
HoldMaintains
$42.20
Edmund Ingham
Forbes
HoldInitiates Coverage
-
Nauman Khan
InvestorPlace
HoldInitiates Coverage
-
Thibault Boutherin
Morgan Stanley
SellDowngrades
$40.00
Indrajit Bandyopadhyay
Zacks Equity Research
HoldInitiates Coverage
-
Kerry Holford
Berenberg Bank
HoldDowngrades
$50.00 → $47.00
Kerry Holford
Berenberg Bank
HoldUpgrades
$50.00 → $47.00
Jasper Hellweg
Argus Research
HoldMaintains
-
James Quigley
Goldman Sachs
HoldMaintains
$48.00 → $44.00
James Quigley
Goldman Sachs
HoldMaintains
$48.00 → $44.00
Andrew Rocco
Zacks Equity Research
SellInitiates Coverage
-

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 22, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for NVO?

The analyst consensus rating for NVO is Hold, based on the latest ratings from 14 analysts over the last 90 days.

What is the average price target for NVO?

The average 12-month price target for NVO is $42.53, representing an upside of 8.7% from the Oct 26, 2026 close of $39.13.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.